Toggle navigation
Catalyst Capital
Home
About
Overview
Guiding Principles
Community
Case Studies
Awards & Recognition
Our Team
Portfolio
News
Contact Us
Investor Login
News
Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development and Manufacturing Business for US$290 Million
September 2017
/ Author: elissa
September 3, 2017 – Business Wire